|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.080 CAD | -0.65% |
|
+0.33% | +14.07% |
| 05-14 | BioRem Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-20 | BioRem Up 15% As Q4 Net Earnings, Revenue Jump | MT |
| Market Cap | 49.95M 35.21M 30.74M 28.46M 26.69M 3.33B 50.29M 338M 131M 1.64B 132M 129M 5.68B | P/E 2026 * |
10.3x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 49.95M 35.21M 30.74M 28.46M 26.69M 3.33B 50.29M 338M 131M 1.64B 132M 129M 5.68B | EV / Sales 2026 * |
1.05x | EV / Sales 2027 * | - |
| Free-Float |
98.07% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.65% | ||
| 1 week | +0.33% | ||
| Current month | -1.91% | ||
| 1 month | -2.84% | ||
| 3 months | +24.70% | ||
| 6 months | +16.67% | ||
| Current year | +14.07% |
| 1 week | 3.06 | 3.15 | |
| 1 month | 3.04 | 3.39 | |
| Current year | 2.26 | 3.57 | |
| 1 year | 1.87 | 3.57 | |
| 3 years | 0.81 | 3.57 | |
| 5 years | 0.42 | 3.57 | |
| 10 years | 0.22 | 3.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Webb
CEO | Chief Executive Officer | - | 2014-12-16 |
Douglas Newman
DFI | Director of Finance/CFO | - | - |
Mark Smit
CTO | Chief Tech/Sci/R&D Officer | - | 2016-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Webb
BRD | Director/Board Member | - | 2014-12-16 |
Alex Gill
BRD | Director/Board Member | - | 2020-06-21 |
William White
CHM | Chairman | 74 | 2020-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-09-23 | Tax | Company | 4,600 | 0.0285% | ||
| 25-09-23 | Tax | Company | 4,600 | 0.0285% | ||
| 25-09-23 | Tax | Company | 20,000 | 0.1241% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.65% | +0.33% | +44.60% | +201.96% | 35.23M | ||
| +1.84% | -2.28% | - | - | 19.11B | ||
| +0.20% | -1.02% | +25.51% | +40.17% | 9.91B | ||
| +4.17% | +1.72% | +245.38% | +646.59% | 5.75B | ||
| -3.29% | +17.35% | +114.08% | +341.44% | 5.07B | ||
| -5.98% | +9.38% | +128.27% | +105.29% | 1.57B | ||
| +1.52% | -1.47% | - | - | 1.49B | ||
| -8.32% | -3.84% | +265.91% | +206.79% | 1.27B | ||
| +1.75% | +7.01% | -20.27% | -20.45% | 963M | ||
| +10.01% | +27.67% | +83.95% | +40.62% | 933M | ||
| Average | +0.12% | +5.34% | +110.93% | +195.30% | 4.61B | |
| Weighted average by Cap. | +0.82% | +0.88% | +111.42% | +246.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.5M 33.49M 29.23M 27.06M 25.38M 3.16B 47.82M 321M 124M 1.56B 126M 123M 5.4B | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 3.080 $ | -0.65% | 6,701 |
| 26-06-18 | 3.100 $ | -0.64% | 5,619 |
| 26-06-17 | 3.120 $ | +0.65% | 11,500 |
| 26-06-16 | 3.100 $ | 0.00% | 9,351 |
| 26-06-15 | 3.100 $ | +0.98% | 9,212 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.080CAD
Average target price
3.500CAD
Spread / Average Target
+13.64%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRM Stock
Select your edition
All financial news and data tailored to specific country editions
















